Qi Wang

Qi Wang

Auto-generated profile, based on publicly available information

Qi Wang

School of Nursing University of Hong Kong Hong Kong Hong Kong

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2024 in Journal of Medical Internet Research
Verified
Journal Article
Open access
XLXufei Luo
Xufei Luo
FCFengxian Chen
Fengxian Chen
DZDi Zhu
Di Zhu
LWLing Wang
Ling Wang
ZWZijun Wang
Zijun Wang
YCYaolong Chen
Yaolong Chen
Large language models (LLMs) such as ChatGPT have become widely applied in the field of medical research. In the process of conducting systematic reviews, similar tools can be used to expedite various steps, including defining clinical questions, performing the literature search, document screening, information extraction, and language refinement, thereby conserving resources and enhancing efficiency. However, when using LLMs, attention should be paid to transparent reporting, distinguishing between genuine and false content, and avoiding academic misconduct. In this viewpoint, we highlight the potential roles of LLMs in the creation of systematic reviews and meta-analyses, elucidating their advantages, limitations, and future research directions, aiming to provide insights and guidance for authors planning systematic reviews and meta-analyses.

28 November 2023 in Pharmacological Research
Verified
Journal Article
Open access
XLXuanlin Li
Xuanlin Li
LHLin Huang
Lin Huang
LWLiaoyao Wang
Liaoyao Wang
XJXin Jin
Xin Jin
QZQi Zhou
Qi Zhou
CWChengping Wen
Chengping Wen
Existing reporting checklists lack the necessary level of detail and comprehensiveness to be used in guidelines on Chinese patent medicines (CPM). This study aims to develop a reporting guidance for CPM guidelines based on the Reporting Items of Practice Guidelines in Healthcare (RIGHT) statement. We extracted information from CPM guidelines, existing reporting standards for traditional Chinese medicine (TCM), and the RIGHT statement and its extensions to form the initial pool of reporting items for CPM guidelines. Seventeen experts from diverse disciplines participated in two rounds of Delphi process to refine and clarify the items. Finally, 18 authoritative consultants in the field of TCM and reporting guidelines reviewed and approved the RIGHT for CPM checklist. We added 16 new items and modified two items of the original RIGHT statement to form the RIGHT for CPM checklist, which contains 51 items grouped into seven sections and 23 topics. The new and revised items are distributed across four sections (Basic information, Background, Evidence, and Recommendations) and seven topics: title/subtitle (one new and one revised item), Registration information (one new item), Brief description of the health problem (four new items), Guideline development groups (one revised item), Health care questions (two new items), Recommendations (two new items), and Rationale/explanation for recommendations (six new items). The RIGHT for CPM checklist is committed to providing users with guidance for detailed, comprehensive and transparent reporting, and help practitioners better understand and implement CPM guidelines.

8 October 2022 in Journal of Clinical Epidemiology
Verified
Journal Article
Closed access
YMYanfang Ma
Yanfang Ma
QWQi Wang
Qi Wang
YDYuting Duan
Yuting Duan
QSQianling Shi
Qianling Shi
XZXuan Zhang
Xuan Zhang
ZBZhaoxiang Bian
Zhaoxiang Bian

27 January 2026 in Journal of Medical Internet Research
Verified
Journal Article
Open access
XSXuping Song
Xuping Song
ZLZhenjie Lian
Zhenjie Lian
RWRui Wang
Rui Wang
RLRuixin Li
Ruixin Li
ZYZhenzhen Yang
Zhenzhen Yang
JLJohn Lavis
John Lavis
Background: Living evidence (LE) synthesis refers to the method of continuously updating systematic evidence reviews to incorporate new evidence. It has emerged to address the limitations of the traditional systematic review process, particularly the absence of or delays in publication updates. The emergence of COVID-19 accelerated the progress in the field of LE synthesis, and currently, the applications of artificial intelligence (AI) in LE synthesis are expanding rapidly. However, in which phases of LE synthesis should AI be used remains an unanswered question. Objective: This study aims to (1) document the phases of LE synthesis where AI is used and (2) investigate whether AI improves the efficiency, accuracy, or utility of LE synthesis. Methods: We searched Web of Science, PubMed, the Cochrane Library, Epistemonikos, the Campbell Library, IEEE Xplore, medRxiv, COVID-19 Evidence Network to support Decision-making, and McMaster Health Forum. We used Covidence to facilitate the monthly screening and extraction processes to maintain the LE synthesis process. Studies that used or developed AI or semiautomated tools in the phases of LE synthesis were included. Results: A total of 24 studies were included, including 17 on LE syntheses, with 4 involving tool development, and 7 on living meta-analyses, with 3 involving tool development. First, a total of 34 AI or semiautomated tools were involved, comprising 12 AI tools and 22 semiautomated tools. The most frequently used AI or semiautomated tools were machine learning classifiers (n=5) and the Living Interactive Evidence synthesis platform (n=3). Second, 20 AI or semiautomated tools were used for the data extraction or collection and risk of bias assessment phase, and only 1 AI tool was used for the publication update phase. Third, 3 studies demonstrated the improvement in efficiency achieved based on time, workload, and conflict rate metrics. Nine studies applied AI or semiautomated tools in LE synthesis, obtaining a mean recall rate of 96.24%, and 6 studies achieved a mean F 1 -score of 92.17%. Additionally, 8 studies reported precision values ranging from 0.2% to 100%. Conclusions: AI and semiautomated tools primarily facilitate data extraction or collection and risk of bias assessment. The use of AI or semiautomated tools in LE synthesis improves efficiency, leading to high accuracy, recall, and F 1 -scores, while precision varies across tools.

1 June 2026 in Annals of Internal Medicine
Verified
Journal Article
Open access
TPThomas Piggott
Thomas Piggott
PSPakeezah Saadat
Pakeezah Saadat
Alina HerrmannAlina Herrmann
Alina Herrmann
ASAirton Tetelbom Stein
Airton Tetelbom Stein
ADAndrea J. Darzi
Andrea J. Darzi
HSHolger Schünemann
Holger Schünemann
Transgression of planetary boundaries, such as biosphere integrity, climate change, and the introduction of new entities like microplastics, may have detrimental effects on human health. Health sys... Human health and natural systems are intrinsically linked—stable natural systems enable healthy human life. Health systems aim to promote, restore, and maintain health. Health systems may promote h...

26 September 2025 in Journal of Medical Internet Research
Verified
Journal Article
Open access
XLXufei Luo
Xufei Luo
ZLZeming Li
Zeming Li
ZYZhenhua Yang
Zhenhua Yang
BWBingyi Wang
Bingyi Wang
YMYanfang Ma
Yanfang Ma
ZBZhaoxiang Bian
Zhaoxiang Bian
Background: Chatbots based on large language models (LLMs) have shown promise in evaluating the consistency of research. Previously, researchers used LLM to assess if randomized controlled trial (RCT) abstracts adhered to the CONSORT-Abstract guidelines. However, the consistency of artificial intelligence (AI) interventional RCTs aligning with the CONSORT-AI (Consolidated Standards of Reporting Trials-Artificial Intelligence) standards by LLMs remains unclear. Objective: The aim of this study is to identify the consistency of RCTs on AI interventions with CONSORT-AI using chatbots based on LLMs. Methods: This cross-sectional study employed 6 LLM models to assess the consistency of RCTs on AI interventions. The sample selection is based on articles published in JAMA Network Open, which included a total of 41 RCTs. All queries were submitted to LLMs through an application programming interface with a temperature setting of 0 to ensure deterministic responses. One researcher posed the questions to each model, while another independently verified the responses for validity before recording the results. The Overall Consistency Score (OCS), recall, inter-rater reliability, and consistency of contents were analyzed. Results: We found gpt-4‐0125-preview has the best average OCS on the basis of the results obtained by JAMA Network Open authors and by us (86.5%, 95% CI 82.5%‐90.5% and 81.6%, 95% CI 77.6%‐85.6%, respectively), followed by gpt-4‐1106-preview (80.3%, 95% CI 76.3%‐84.3% and 78.0%, 95% CI 74.0%‐82.0%, respectively). The model with the worst average OCS is gpt-3.5-turbo-0125 on the basis of the results obtained by JAMA Network Open authors and by us (61.9%, 95% CI 57.9%‐65.9% and 63.0%, 95% CI 59.0%‐67.0%, respectively). Among the 11 unique items of CONSORT-AI, Item 2 (“State the inclusion and exclusion criteria at the level of the input data”) received the poorest overall evaluation across the 6 models, with an average OCS of 48.8%. For other items, those with an average OCS greater than 80% across the 6 models included Items 1, 5, 8, and 9. Conclusions: GPT-4 variants demonstrate strong performance in assessing the consistency of RCTs with CONSORT-AI. Nonetheless, refining the prompts could enhance the precision and consistency of the outcomes. While AI tools like GPT-4 variants are valuable, they are not yet fully autonomous in addressing complex and nuanced tasks such as adherence to CONSORT-AI standards. Therefore, integrating AI with higher levels of human supervision and expertise will be crucial to ensuring more reliable and efficient evaluations, ultimately advancing the quality of medical research.